Development and evaluation of a double antibody sandwich ELISA for the detection of human sDC-SIGN

作者：Chen, Shang-Liang; Li, Yan-Li; Tang, Yuan; Chen, Zhi-Cheng; Zhou, Jing; Zhou, Jia; Lu, Xiao; Zhao, Na; Chen, Zheng-Liang^*; Zuo, Daming^*

来源：Journal of Immunological Methods, 2016, 436: 16-21.

DOI：10.1016/j.jim.2016.05.011

• sDC-SIGN
• CD209
• sandwich MASA
• chronic hepatitis B virus infection

sDC-SIGN is the soluble form of dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN, CD209), which is a molecule involved with pathogen recognition and immune regulation. However, there is no commercially available ELISA kit for detecting human sDC-SIGN, and the normal range of this molecule is unknown. Here, we describe an ELISA for detecting human sDC-SIGN with high specificity. First, sDC-SIGN protein was expressed and purified. Monoclonal and polyclonal antibodies were then raised against the purified protein and subsequently characterized. A sandwich ELISA was developed using polyclonal antibodies specific for sDC-SIGN for capture and a biotin-labeled monoclonal antibody specific for sDC-SIGN for detection of protein. This method has sensitivity up to 0.2 ng/ml. Using this ELISA, we found that the concentration of sDC-SIGN in sera of healthy volunteers ranges from 0-319 ng/ml with a mean concentration of 27.14 ng/ml. Interestingly, the concentration of sDC-SIGN in sera from patients with cancer or chronic hepatitis B virus (CHB) infection was lower than that of health controls. The mean concentrations of sDC-SIGN in cancer patients and chronic hepatitis B virus infection patients were 3.2 ng/ml and 3.8 ng/ml, respectively. We developed a sandwich ELISA for detecting human sDC-SIGN and demonstrated its use by assessing sera concentrations of sDC-SIGN in patients with cancer and chronic CHB infection compared to that of healthy controls.

• 出版日期2016-9
• 单位南方医科大学